Skip to content

Study · Measured the body's own peptide · 1995

1 result

Intracellular degradation of the C-peptide of proinsulin, in a human insulinoma: identification of sites of cleavage and evidence for a role for cathepsin B.

Conlon JM, Höög A, Grimelius L

Pancreas1 Mar 1995Cited by 10 (Europe PMC)

PMID7716141 (opens in a new tab)DOI10.1097/00006676-199503000-00010 (opens in a new tab)PepBankPUB-07716141
Publisher pagePubMedAsk about this study
Jump to 1 result

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study1

No result from this study comes from a test of the peptide.

Natural levels measured1

These results measure the body's own peptide. Nobody was given the peptide. They are not evidence about taking it. They are left out of key results, evidence counts and charts.

  1. 01HumanEndogenous levelCase report or seriesOther

    A human pancreatic neuroendocrine tumor extract contained thymosin beta‑4, together with insulin, C-peptide, somatostatin and calcitonin.

    In plain wordsA human pancreatic tumor extract contained the body's own thymosin beta‑4, along with other hormones.

    Peptide
    Thymosin beta-4 (human)
    Outcome
    Not applicableThymosin beta 4 content of insulinoma extract
    Study

    n = 1

    human insulinoma extract
    Outcome group
    Gene expression · Cancer

    Source sentences

    Summary
    An extract of a neuroendocrine tumor of the human pancreas contained a high concentration of insulin and the C-peptide of proinsulin, as determined by radioimmunoassay, together with somatostatin, calcitonin, and thymosin beta 4.

    This result measures the body's own Thymosin beta-4 (human). Nobody was given the peptide. It is not evidence about taking it.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    13 Oct 2026, 01:52 UTC

    Study results updated

  2. Version 1

    12 Oct 2026, 18:17 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.